"Neglected tropical diseases" (NTDs) are a specific set of chronic infectious diseases found primarily in tropical areas. They include (but are not limited to) a variety of intestinal worms, the painfully disfiguring disease lymphatic filariasis, and the blinding diseases trachoma and river blindness. They do not include such well-known diseases as AIDS, tuberculosis and malaria. While most NTDs do not directly cause death, they can have debilitating consequences such as malnutrition, blindness, disfigurement, anemia, and low energy.3
Fortunately many NTDs are cheaply and safely treatable. For many of the diseases a yearly dose of a combination of drugs administered to all residents of at-risk areas can effectively and inexpensively reduce prevalence.4
| Program | Result | Cost-effectiveness (best case) | More information |
|---|---|---|---|
| Mass drug administration to control lymphatic filariasis | Program reduces lymphatic filariasis rates | $100 prevents 15-85 total years of lymphedema (swollen limbs) and 25-165 total years of hydrocele (swollen scrotum) | In-depth evidence review |
| Mass drug administration to control river blindness | Program is effective in suppressing the worms that cause river blindness | $100 prevents 2.5-14 years of blindness; 3.5-20 years of irritating skin disease; and 3-17 years of impaired vision | In-depth evidence review |
| SAFE Strategy to control trachoma | Surgery reduces the scarring that leads to blindness, and antibiotics reduce infection rates | Surgeries: $100 prevents 1-30 years of blindness and 1-30 years of low vision. Other components: highly costly or unknown. | In-depth evidence review |
| Combination deworming program | Medications are effective at treating schistosomiasis and soil-transmitted helminths | $3.50 per additional year of school attendance for students | In-depth evidence review |
From what we've seen, the major organizations focused on deworming work heavily with developing-world governments. They spend money on both advocacy and subsidies for government control programs. We therefore have the following questions:
We have not yet found a charity addressing NTDs whose impact we can be confident in.
Two charities we've reviewed that focus heavily on NTDs include:
For background information on NTDs, see our summary of disease facts.
The Disease Control Priorities Project estimates that 31% of sub-Saharan Africans are infected with schistosomiasis (parasitic worm), and 3% with lymphatic filariasis. Trachoma and onchocerciasis (river blindness) are significantly less prevalent in Africa overall, but may be highly endemic in certain areas. Data from WHO, "Prevalence for Selected Causes in WHO Regions (2004)" (XLS).
More at our disease facts page.
See our comparative summary of proven programs, which includes programs to combat NTDs. Additionally, see our full reviews of drug distribution programs for lymphatic filariasis, drug distribution programs for river blindness, the SAFE program for trachoma, and deworming programs.